Results 151 to 160 of about 35,477 (203)

EndoCompass Project: Research Roadmap for Pituitary and Neuroendocrine Tumor Endocrinology.

Horm Res Paediatr
Castano JP, Dattani MT, Grozinsky-Glasberg S, Karavitaki N, Pavel ME, Andoniadou C, Alexandraki K, Capatina C, Cerbone M, Ferone D, Gan HW, Hofland J, Hofland L, Ibanez-Costa A, Ilie MD, Isidori AM, Korbonits M, Kos-Kudła B, Maghnie M, Mantovani G, Marazuela M, Raverot G, Scarpa A, Schilbach K, Theodoropoulou M, van Santen HM, Zatelli MC.   +26 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Malignant carcinoid syndrome: Two case reports

Journal of Surgical Oncology, 1980
AbstractThe malignant carcinoid syndrome (MCS) is a rare complication of malignant carcinoid neoplasms, fewer than 200 cases having been reported since its description by Thorson in 1954. Its signs and symptoms vary with the site of the primary neoplasm, and MCS is now recognized as one member of the large family of endocrine tumors ‐ APUDOMAS ...
J L, Spann, D, Van Wormer, M E, Sandlin
exaly   +3 more sources

Cutaneous manifestations of the malignant carcinoid syndrome

British Journal of Dermatology, 2005
The incidence of carcinoid tumours is approximately 1.5 per 100 000 of the population. The malignant carcinoid syndrome, which is caused by circulating neuroendocrine mediators produced by the tumour, occurs in less than 10% of patients. Cutaneous involvement, although recognized in this rare syndrome, has rarely been reported.To examine a series of ...
H K, Bell, G J, Poston, J, Vora, N J E, Wilson   +3 more
exaly   +3 more sources

Therapy of the Malignant Carcinoid Syndrome

Endocrinology and Metabolism Clinics of North America, 1989
Although usually associated with carcinoid tumors of the small intestine that have metastasized to the liver, the carcinoid syndrome is seen less frequently with primary tumors arising from other organs such as the lung, pancreas, thymus, stomach, and ovary.
exaly   +3 more sources

Malignant Carcinoid Syndrome Associated with Noncarcinoid Tumors

New England Journal of Medicine, 1965
DURING the past decade the "malignant carcinid syndrome" has been a favored subject in the medical literature because of the dramatic nature of its acute and chronic clinical manifestations and of its as yet unresolved challenges to the physiologist and therapist.
Charles G. Moertel, Oliver H. Beahrs, Lewis B. Woolner, Gertrude M. Tyce   +3 more
exaly   +2 more sources

Therapy of the Malignant Carcinoid Syndrome

Annals of Internal Medicine, 1965
Excerpt The therapy of the malignant carcinoid syndrome presents a unique challenge to physicians caring for patients with this unusual disease.
exaly   +3 more sources

Diagnosis and Treatment of Malignant Carcinoid Syndrome

JAMA - Journal of the American Medical Association, 1974
THE malignant carcinoid syndrome has challenged the skills of the clinician, biochemist, and pharmacologist since its original description by Biorck et al 1 22 years ago. Although attention originally centered on a symptom complex and a serotonin-producing midintestinal neoplasm that had metastasized to the liver, the carcinoid syndrome has now been ...
exaly   +3 more sources